mRNA |
HC-067047 |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.06 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.06 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.06 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.07 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.07 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.07 |
mRNA |
BRD-K33199242 |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.07 |
mRNA |
KU-55933 |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.07 |
mRNA |
sitagliptin |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.07 |
mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.08 |